Matches in Wikidata for { <http://www.wikidata.org/entity/Q92016890> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q92016890 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q92016890 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92016890 description "scientific article published on 17 April 2020" @default.
- Q92016890 description "wetenschappelijk artikel" @default.
- Q92016890 description "наукова стаття, опублікована 17 квітня 2020" @default.
- Q92016890 name "Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patientscompared to cyclosporine A and methotrexate: results from the BioDay registry" @default.
- Q92016890 name "Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patientscompared to cyclosporine A and methotrexate: results from the BioDay registry" @default.
- Q92016890 type Item @default.
- Q92016890 label "Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patientscompared to cyclosporine A and methotrexate: results from the BioDay registry" @default.
- Q92016890 label "Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patientscompared to cyclosporine A and methotrexate: results from the BioDay registry" @default.
- Q92016890 prefLabel "Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patientscompared to cyclosporine A and methotrexate: results from the BioDay registry" @default.
- Q92016890 prefLabel "Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patientscompared to cyclosporine A and methotrexate: results from the BioDay registry" @default.
- Q92016890 P1433 Q92016890-A1FD6A11-2B85-474B-A6C4-7C0A7A037FA5 @default.
- Q92016890 P1476 Q92016890-4671E631-BA87-48D6-AA4F-572D92280DC7 @default.
- Q92016890 P2093 Q92016890-06C91242-19EE-473E-BABB-505DB5353C43 @default.
- Q92016890 P2093 Q92016890-0C7F7EEE-3A6C-4F9B-AAAE-2BAC7CAD6A7F @default.
- Q92016890 P2093 Q92016890-44F742D8-0B86-439A-A77F-F6941B9218A5 @default.
- Q92016890 P2093 Q92016890-58A61D79-31D6-45CC-A7D8-D834044B6442 @default.
- Q92016890 P2093 Q92016890-618F90DE-7964-4D4A-A514-7D77D6C64020 @default.
- Q92016890 P2093 Q92016890-67FDE52B-8B56-4904-89AC-7692C9804BC2 @default.
- Q92016890 P2093 Q92016890-8273FDCA-F802-43F6-AA50-350F062BAE3D @default.
- Q92016890 P2093 Q92016890-A797D13C-38FF-408D-A309-08D5277E494C @default.
- Q92016890 P2093 Q92016890-AC70379A-D39A-48F8-997B-369D68EFEC56 @default.
- Q92016890 P2093 Q92016890-D4F89B47-32BA-48CF-B710-CCF7B6C530AB @default.
- Q92016890 P2093 Q92016890-D9897089-4598-462D-B650-27F4E834C464 @default.
- Q92016890 P2093 Q92016890-F5DA7032-20AA-4A5A-88FD-9AC9BBAD9C79 @default.
- Q92016890 P2093 Q92016890-F95B628B-EE2A-4028-961B-31001F73A974 @default.
- Q92016890 P31 Q92016890-8AF2C053-AB2D-44BF-9AE0-64B9CFBB6A57 @default.
- Q92016890 P356 Q92016890-379DC867-165B-416F-8342-5CD8292CE46A @default.
- Q92016890 P50 Q92016890-02227BE0-ED17-4293-B854-2C37C2BD9609 @default.
- Q92016890 P577 Q92016890-CC4CAA38-FB24-461E-BC11-5DD92F62DD3D @default.
- Q92016890 P698 Q92016890-26C83336-443D-4F60-8CEF-82DD1EA9D60D @default.
- Q92016890 P921 Q92016890-61CB5E08-BFF2-4C77-9A4D-CFC41518CA7E @default.
- Q92016890 P921 Q92016890-6E1173B3-4356-4B51-BD00-93C35DE0FE6D @default.
- Q92016890 P921 Q92016890-BF1F37DA-B7A0-4A81-A6A9-6792CC3DF5CE @default.
- Q92016890 P356 ALL.14324 @default.
- Q92016890 P698 32302412 @default.
- Q92016890 P1433 Q2699825 @default.
- Q92016890 P1476 "Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patientscompared to cyclosporine A and methotrexate: results from the BioDay registry" @default.
- Q92016890 P2093 "Albert J Oosting" @default.
- Q92016890 P2093 "Annemiek Sloeserwij" @default.
- Q92016890 P2093 "Daphne S Bakker" @default.
- Q92016890 P2093 "Geertruida LE Romeijn" @default.
- Q92016890 P2093 "Ilona de Ridder" @default.
- Q92016890 P2093 "Inge Haeck" @default.
- Q92016890 P2093 "Jorien van der Schaft" @default.
- Q92016890 P2093 "Judith L Thijs" @default.
- Q92016890 P2093 "Lieneke Fm Ariëns" @default.
- Q92016890 P2093 "Lotte S Spekhorst" @default.
- Q92016890 P2093 "Marijke Kamsteeg" @default.
- Q92016890 P2093 "Marjolein S de Bruin-Weller" @default.
- Q92016890 P2093 "Marlies de Graaf" @default.
- Q92016890 P31 Q13442814 @default.
- Q92016890 P356 "10.1111/ALL.14324" @default.
- Q92016890 P50 Q41172882 @default.
- Q92016890 P577 "2020-04-17T00:00:00Z" @default.
- Q92016890 P698 "32302412" @default.
- Q92016890 P921 Q268667 @default.
- Q92016890 P921 Q367700 @default.
- Q92016890 P921 Q422232 @default.